SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-008065
Filing Date
2023-11-14
Accepted
2023-11-14 11:15:31
Documents
68
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR SEPT 2023 aclarion_i10q-093023.htm   iXBRL 10-Q 1077291
2 CERTIFICATION aclarion_ex3101.htm EX-31.1 10452
3 CERTIFICATION aclarion_ex3102.htm EX-31.2 10504
4 CERTIFICATION aclarion_ex3201.htm EX-32.1 3884
5 CERTIFICATION aclarion_ex3202.htm EX-32.2 3989
  Complete submission text file 0001683168-23-008065.txt   5504886

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE acon-20230930.xsd EX-101.SCH 42826
7 XBRL CALCULATION FILE acon-20230930_cal.xml EX-101.CAL 50274
8 XBRL DEFINITION FILE acon-20230930_def.xml EX-101.DEF 189864
9 XBRL LABEL FILE acon-20230930_lab.xml EX-101.LAB 322323
10 XBRL PRESENTATION FILE acon-20230930_pre.xml EX-101.PRE 283814
62 EXTRACTED XBRL INSTANCE DOCUMENT aclarion_i10q-093023_htm.xml XML 777728
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

IRS No.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41358 | Film No.: 231402713
SIC: 8071 Services-Medical Laboratories